Long-term effect of early treatment with interferon beta-1b after a first 
clinical event suggestive of multiple sclerosis: 5-year active treatment 
extension of the phase 3 BENEFIT trial

Kappos, Ludwig; Freedman, Mark S.; Polman, Chris H.; Edan, Giles; Hartung, Hans-Peter; Miller, David H.; Montalbán, Xavier; Barkhof, Frederik; Radü, Ernst-Wilhelm; Metzig, Carola; Bauer, Lars; Lanius, Vivian; Sandbrink, Rupert; Pohl, Christoph; BENEFIT Study Group,; Villringer, Arno

doi:10.1016/S1474-4422(09)70237-6

DetailsSummary

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., et al. (2009). Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurology, 8(11), 987-997. doi:10.1016/S1474-4422(09)70237-6.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0011-2D58-C Version Permalink: https://hdl.handle.net/11858/00-001M-0000-002B-F985-A

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Kappos, Ludwig¹, Author
Freedman, Mark S.², Author
Polman, Chris H.³, Author
Edan, Giles⁴, Author
Hartung, Hans-Peter⁵, Author
Miller, David H.⁶, Author
Montalbán, Xavier⁷, Author
Barkhof, Frederik³, Author
Radü, Ernst-Wilhelm¹, Author
Metzig, Carola⁸, Author
Bauer, Lars⁸, Author
Lanius, Vivian⁸, Author
Sandbrink, Rupert^{5, 8}, Author
Pohl, Christoph^{8, 9}, Author
BENEFIT Study Group, Author
Villringer, Arno¹⁰, Author

Affiliations:
1University Hospital, Basel, Switzerland, ou_persistent22
2Ottawa Hospital-General Campus, Ottawa, ON, CA, ou_persistent22
3Vrije Universiteit Medical Center, Amsterdam, the Netherlands, ou_persistent22
4Centre Hospitalier Universitaire, Rennes, France, ou_persistent22
5Heinrich-Heine-Universität, Düsseldorf, Germany, ou_persistent22
6National Hospital for Neurology and Neurosurgery, London, United Kingdom, ou_persistent22
7Hospital Vall d'Hebron, Barcelona, Spain, ou_persistent22
8Bayer Schering Pharma AG, Berlin, Germany, ou_persistent22
9University Hospital Bonn, Germany, ou_persistent22
10Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society, ou_634549

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2009-11

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: eDoc: 547139
Other: P11628
DOI: 10.1016/S1474-4422(09)70237-6

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Lancet Neurology

Other : Lancet Neurol.

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: London, UK : Elsevier

Pages: - Volume / Issue: 8 (11) Sequence Number: - Start / End Page: 987 - 997 Identifier: ISSN: 1474-4422
CoNE: https://pure.mpg.de/cone/journals/resource/111025286560038